Evaluation of the N.C. Prescription

Similar documents
North Carolina, like the rest of the nation, has been experiencing

Using the NC Controlled Substances Reporting System to Identify Providers Manifesting Unusual Prescribing Practices

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

Scott Kirby, M.D, Medical Director, North Carolina Medical Board. Chris Ringwalt, Dr.P.H., Senior Scientist, UNC Injury Prevention Research Center

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Presentation Objectives

Report to the Legislature: Unsolicited Reporting Criteria Established and Process Review MN Prescription Monitoring Program

The Wisconsin Prescription Drug Monitoring Program

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

Report to the Legislature: Recommendations on Required Use and Other Uses of the MN Prescription Monitoring Program Database

Confronting the Opioid Epidemic

Oregon Prescription Drug Monitoring Program

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Prescription Opioid Overdose in Oregon: A public health perspective

Medicare Advantage Outreach and Education Bulletin

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017

Maine PMP Update. Daniel Eccher, MPH MPA Convention May 20, 2011

PDMP Tools to Identify Red Flag Situations

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting

Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017

Preventing Opioid Misuse in Texas

NC General Statutes - Chapter 90 Article 5E 1

Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

State of California Department of Justice. Bureau of Narcotic Enforcement

Medicare Advantage Outreach and Education Bulletin

Curbing Prescription Drug Abuse in Medicaid

State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP

Best Practices and Foundation Forum. Fred Wells Brason II

Arkansas Department of Health

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System

ACCG Mental Health Summit

Tracker e-prescribing 101. The Complete Guide

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Prescription Drug Monitoring Programs and Other State-Level Strategies

Addressing Prescription Drug Abuse. Allan Coukell Senior Director, Drugs and Medical Devices The Pew Charitable Trust

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

Technical Assistance Guide No Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors

Prescription Monitoring Program: Law Enforcement Responsibilities National Conference of State Legislatures

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort

PRESCRIPTION DRUG MONITORING PROGRAM

California. Prescribing and Dispensing Profile. Research current through November 2015.

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Key Findings and Recommendations from the

Potential Solutions to Epidemic Substance Abuse in US and Europe

Michigan Legislative and Regulatory Pharmacy Initiatives Update

May 25, Drug Overdose Update & Response: Combatting Opioid Overdose

Arkansas Prescription Monitoring Program

COLORADO PRESCRIPTION DRUG MONITORING PROGRAM

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2017 (2017Q3)

Prescription Monitoring Program (PMP)

Naloxone and Combating the Opioid Epidemic

Proposed Amendment of 10A NCAC 26E.0603 Requirements for Transmission of Data

Pennsylvania Prescription Drug Monitoring Program Trends,

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)

E-Prescribing, EPCS & PDMP: An Update

Oregon Opioid Overdose Prevention Initiative

MARYLAND BOARD OF PHARMACY

Prescribing Controlled Substances and the PDMP

Reducing opioid overdose mortality: role of communityadministered

Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018

ASTHO President s Challenge 15 x 15: Reduce Prescription Drug

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Using PDMP Data to Guide Interventions with Possible At-Risk Prescribers

WA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Prescription Drugs: Issues in Treatment, Supervision and Case Management

Aetna s Initiative on the Opioid Epidemic

Unintentional Poisonings: Public Health Response Joint Legislative Health Care Oversight Committee

Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina

PDMP prescriber use mandates: characteristics, current status, and outcomes in selected states

Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York

ANNUAL REPORT

BJA COAP Category 6 Quarterly Webinar November 29, 2018

Medicare Part D Opioid Policies for 2019 Information for Patients

2125 Rayburn House Office Building 2125 Rayburn House Office Building Washington, DC Washington, DC 20515

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Opioid Overdose in Oregon Report to the Legislature

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Presentation Overview

High-Decile Prescribers: All Gain, No Pain?

Data-Driven Multidisciplinary Approaches to Reduce Prescription Drug Abuse in Kentucky

Overcoming the Substance Abuse Epidemic: One Member at a Time

Prescription Monitoring Programs: An Update on Interstate Data Sharing

Do you CARA? A Deep Dive Into the Comprehensive Addiction and Recovery Act Joel White, President

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

Wednesday, June 21, Dear Chairmen and Ranking Members:

Transcription:

Evaluation of the N.C. Prescription Drug Monitoring Program 2013 National Meeting of the Safe States Alliance and SAVIR MarianaGarrettson Garrettson, MPH Chris Ringwalt, DrPH UNC Injury Prevention Research Center William Bronson, Project Officer NC Department of Health and Human Services

Source of support Funding for this study has been provided through a contract with the NC Department of Health and Social Services, Division of Mental Health, Developmental Disabilities and Substance Abuse Services, funded by Grant # 2009 PM BX 0008 awarded by the Bureau of Justice Assistance, Office of Justice Programs, U.S. Department of Justice. Neither the U.S. Department of Justice nor any of its components operate, control are responsible for, or necessarily endorse this report (including, without limitation, its content, technical infrastructure, and policies, and any services or tools provided).

What is a Prescription Drug Monitoring Program (PDMP)? To collect data on prescription drugs as they are dispensed and to make these data available for various uses, including patient care, public health surveillance, and law enforcement investigations relating to drug diversion and insurance fraud. All 50 states have enacted PDMPlegislation and 41 have operational programs in place

Mandate of the NC Controlled Substances Reporting System (CSRS) improve the State s ability to identify controlled substance abusers or misusers and refer them for treatment, and to identify and stop diversion of prescription drugs in an efficient and cost effective manner that will not impede the appropriate medical utilization of licit controlled substances.

NC CSRS Timeline 2005: Legislature establishes CSRS August 2008: Pharmacies report bimonthly June 2011 June 2012: Evaluation conducted July 1, 2007: System starts: pharmacies report monthly January 2012: Pharmacies report weekly January 2013: Legislation to update system proposed

Two part study 1. User survey 2. Impact analysis of three years of data

Research Questions: Part 1 1. Among those not registered to use the system, why are they not registered? 2. Among those who are registered and are using the system: a) what htti triggers them to make a query on a patient? b) how has their use of the system changed their practice?

Part I: Prescriber and Dispenser Surveys (convenience samples, 2012) Prescribers Sample sources: CSRS vendor (registered prescribers only) N.C. Medical Society (all prescribers who gave permission) Respondents: N=1462 Dispensers Sample source: N.C. Board of Pharmacy (all pharmacists) Respondents: N=1703

Results of Prescriber Survey

Why have you NOT registered? Why have you NOT registered? (N=202) Did not know about it I am too busy to look up patient information. I do not prescribe controlled substances. No time to register ('haven't gotten around to it') 0 10 20 30 40 50 60 I tried to enroll but I never heard back. 5 I use someone else's log in. 4 4 Does not apply to my setting 4 1. I did not I do have know Internet access about at work. it 2. I do Misperception not anticipate (thought it was only for ) that I would ever use the system I tried to enroll but CSRS crashed my computer. 3. I am too busy to look up patient information 2 2 2 2 1 1 1 1 0 0 10 9 9 8 15 13 Rely on other information sources (e.g. pharmacists) 4. It does not seem worth my time I do not have an email address that only I can access. 5. I do not prescribe controlled substances 18 42 49

Reasons that prescribers query the CSRS 1. Patient behavior suggests possible addiction or substance abuse 2. Requests for early refills of controlled substances 3. Request specific drugs 4. Long term prescription for controlled substance 5. Known history of addiction

Effects on clinical practice

Effects on clinical practice (cont.)

Results of Pharmacist Survey

Reasons pharmacists have not registered 1. I did not know about it 2. I do not anticipate that I would ever use the system 3. I do not have a DEA number 4. I do not dispensecontrolled substances 5. I do not have internet access at work

Reasons for which pharmacists query the CSRS 1. Prescription profile suggests addiction, abuse 2. Requests for early refills 3. Behavior suggests possible addiction or abuse 4. New patients 5. Specific personal knowledge 6. Physical appearance 7. Dispensing i any controlled substance bt 8. Long term prescription for controlled substance

Contacting Prescribers about Patients Have you ever used information from the CSRS when you called a prescriber about a patient? (N=482) Didthe prescriberchange change the prescription? (N=390)

Key findings from Surveys Continued lack of awareness of the system among prescribers and pharmacists Main reasons for querying the system are appropriate, focus on abuse Use of the system increases prescribers : ability to identify potential abusers confidence in writing and denying prescriptions Both prescribers and pharmacists report using the system to facilitate communication between groups

PART II: Analysis of CSRS data

Research Questions To what extent has the CSRS : Enhanced the identification of misusers and abusers of controlled substances Increased the extent to which abusers and misusers of controlled substances are referred to treatment Impeded appropriate medical utilization of licit controlled substances Identified and decreased the diversion of prescription medications

Methods 3 years of data (2009 2011) Divided for descriptive purposes into 6 6 month blocks (identified as Spring and Fall) Definitionof of at risk for overdose : patients with prescriptions: prescribed by 4+ prescribers AND dispensed by 4+ pharmacies WITHIN any 6 month period Utilization by providers measured as number of days in which queries were made

Utilizers querying the NC CSRS, 2009 11 5000 4500 4000 3500 3000 2500 2000 1500 1000 500 0 Number of utilizers 4569 4201 3701 3114 2526 1996 2009 S 2009 F 2010 S 2010 F 2011 S 2011 F

Average number prescriptions for a controlled substance/patient, 2009 11 4 3.5 3 2.5 2 1.5 1 0.5 0 3.38 Mean # prescriptions pesc pto s 3.5 3.52 3.55 3.51 3.58 2009 S 2009 F 2010 S 2010 F 2011 S 2011 F

Drug seeking behaviors Dramatic decrease in patients: 15 prescribers AND 15 pharmacists in 6 months 10 prescribers AND 10 pharmacists in 6 months No change in numbers of patients: Identified by current NC criterion for unusual pattern (10 prescribers OR 5 pharmacists in 3 months) At high risk for overdose (4/4 prescribers AND pharmacists in 6 months)

Prescriptions written in N.C. for Benzodiazepines i and Opioids, id 2009 11 4500000 4000000 3500000 3000000 2009 S 2500000 2000000 1500000 1000000 500000 2009 F 2010 S 2010 F 2011 S 2011 F 0 Benzodiazepines Opioids

Prescriptions written in N.C. for treatment 120000 of opioid iddependence, d 2009 11 103,699 100000 91,914 82,376 80000 2009 S 70,873 2009 F 59,472 60000 2010 S 45,241 2010 F 40000 2011 S 20000 2011 F 0 Buprenorphine

CSRS use associated with patients receiving Bupenorphine

Key Findings Steady increase in providers registered for and using thecsrs However, the total number registered, as a proportion of all providers who are eligible to register for the CSRS (30%), remains low. CSRS has not decreased legitimate prescribing. Reductions in # patients meeting strictest drug seeking definition Consistent CSRS utilization strongly associated with the likelihood that high risk patients receive opioid iddependence d treatment

Full report can be downloaded from: www.iprc.unc.edu/nccontrolledsubs.shtml

Like to know more? Contact information: Mariana Garrettson, MPH Injury Prevention Research Center University of North Carolina marianag@unc.edu